BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 30
• 31

• Pharm Country

  Plandai Biotechnology, Inc.: A Natural Fit Into The Marijuana Industry

  March 4, 2014

   · 

  2 min read
• Business

  Ocera Therapeutics, Inc. To Announce Fourth Quarter And Year End Financial Results

  March 4, 2014

   · 

  1 min read
• BioCapital

  MacroGenics, Inc. To Present At The 26th Annual ROTH Conference

  March 4, 2014

   · 

  1 min read
• Business

  Amicus Therapeutics, Inc. Announces Full-Year 2013 Financial Results And Corporate Updates

  March 4, 2014

   · 

  1 min read
• Business

  Merit Medical Systems, Inc. Announces Sales And Earnings Guidance For 2014

  March 4, 2014

   · 

  1 min read
• Business

  NuVasive, Inc. Reports Fourth Quarter And Full Year 2013 Financial Results

  March 4, 2014

   · 

  1 min read
• Business

  Dynavax Technologies Corporation To Receive $5.4 Million Milestone

  March 4, 2014

   · 

  2 min read
• Drug Development

  Boston Therapeutics, Inc. To Initiate A Phase II Clinical Study Of BTI-320 In U.S.

  March 4, 2014

   · 

  5 min read
• Drug Development

  Janssen Pharmaceutica N.V. Release: New Data Show XEPLION® Significantly Delays Time To Relapse Compared To Treatment As Usual With Oral Antipsychotic Monotherapy

  March 4, 2014

   · 

  1 min read
• New Roche Chairman Promises To Follow Predecessor’s Tight-Fisted Ways, Eyes Acquisitions

  March 4, 2014

   · 

  1 min read